Disease Studies

News & Media

See below for details of all PrecisionLife news, events and media activity as well as links to Disease Studies, research, and publications.


Why does chronic disease drug discovery & development need fixing?

The blockbuster model for drug discovery and development in chronic diseases is inefficient and costly. We need a new…

12/10/21
Read more

BIA Tech Bio Meet Up

15 December 2021 PrecisionLife, Chief Executive Officer, Dr Steve Gardner, is joining the BIA Tech Bio Meet Up on…

15/12/21
Read more

BREATHE Industry Forum

15 December 2021 PrecisionLife, Chief Medical Officer, Dr Veronique Bouchet, is speaking at the BREATHE Industry Forum on 15…

15/12/21
Read more

Future of Precision Medicine Symposium

Copenhagen, 22-23 November 2021 Co-founders of PrecisionLife, Chief Executive Officer Steve Gardner, PhD and Chief Analytics Officer Gert L…

22/11/21
Read more

BioData World Congress 2021

Basel, 2-4 November 2021 PrecisionLife is attending the BioData World Congress 2021. The event is Europe’s largest congress covering…

22/10/21
Read more

BIO Europe 2021

Online, 25-28 October 2021 PrecisionLife is attending the international BIO Europe 2021 gathering alongside global biopharma and investment leaders…

22/10/21
Read more

UK BioIndustry Association launches first TechBio company report

OXFORD, UK: PrecisionLife featured as a case study of how a data-driven techbio company is transforming drug discovery and…

15/10/21
Read more

BIA Bioscience Forum

London, 14 October 2021 PrecisionLife CEO, Dr Steve Gardner, will join an expert panel at the BIA Bioscience Forum…

6/10/21
Read more

WEBINAR: Disease Mechanisms and Target Discovery

PrecisionLife CEO, Dr Steve Gardner, joins Cyclica CEO, Naheed Kurji in a webinar exploring Disease Mechanisms and Target Discovery….

6/10/21
Read more

Anyone for tea? Why Alzheimer’s drug discovery might be targeting the impossible

Unique approach to precision medicine could reverse the trend in Alzheimer’s disease drug discovery and development Clinical trials in…

27/09/21
Read more

Neuropsychiatric Drug Development Summit

Online, 29-30 September 2021 Members of the PrecisionLife team will join leaders from the likes of Sunovion, Merck, Takeda,…

24/09/21
Read more

Best Chronic Disease Biology Company 2021 awarded to PrecisionLife

OXFORD, UK The International Life Sciences Awards has named PrecisionLife as the Best Chronic Disease Biology R&D Company 2021.

20/09/21
Read more

Complexity of disease biology gives opportunities for drug discovery

Late-stage clinical trials incur the biggest costs of bringing new drugs to market. Increasingly clinical trial failures happen late….

1/09/21
Read more

Understanding AI and its important role in MND research

“The search for new drugs to help people living with MND is long and challenging, but it is one…

22/07/21
Read more

Precision medicine and chronic disease

Chronic diseases, which account for 85% of healthcare costs, still have significant remaining pockets of unmet medical need that…

15/07/21
Read more

Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients

The study undertaken by PrecisionLife and Optum Labs leaders Taryn O. Hall and Kathy T.H. Zheng using data from…

8/07/21
Read more

Chairman Q&A: from Pepsi to PrecisionLife

A Q&A with PrecisionLife Executive Chairman Ray Pawlicki reflecting on a senior leadership career that moved from Pepsico, to…

24/06/21
Read more

Keep in touch

Please enter your email address if you would like to be kept informed of our work here at PrecisionLife. Note that our Privacy Policy and Terms & Conditions apply.